DR REDDYS LABORATORIES LTD Initial Statement of Beneficial Ownership

DR REDDYS LABORATORIES LTD filed an initial insider ownership report for Israeli Erez, who is listed as the company’s CHIEF EXECUTIVE OFFICER.

Accepted by SEC EDGAR 04/01/2026 - 11:28 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD filed an initial insider ownership report for Israeli Erez, who is listed as the company’s CHIEF EXECUTIVE OFFICER. This Form 3 shows no reported purchases, sales, or other transactions in the company’s securities and provides only role and status information.

Key Terms

Form 3, CHIEF EXECUTIVE OFFICER, reportingPersons

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

CHIEF EXECUTIVE OFFICER financial

""officer_title": "CHIEF EXECUTIVE OFFICER""

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

reportingPersons regulatory

""reportingPersons": ["

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DR REDDYS LABORATORIES (RDY) Form 3 for Israeli Erez show?

The Form 3 lists Israeli Erez as an officer and CHIEF EXECUTIVE OFFICER of DR REDDYS LABORATORIES LTD. It reports no purchases, sales, or other transactions, only establishing his status as a reporting person.

Does the RDY Form 3 for Israeli Erez report any share purchases or sales?

No, the filing’s transaction summary shows zero buy, sell, acquire, dispose, or other transactions. All transaction-related share counts are listed as 0, indicating no trades were reported in this initial ownership statement.

What position does Israeli Erez hold at DR REDDYS LABORATORIES LTD?

Israeli Erez is identified as an officer of DR REDDYS LABORATORIES LTD with the title CHIEF EXECUTIVE OFFICER. The Form 3 confirms his executive role but does not list any current security holdings or trades.

Is Israeli Erez reported as a 10% owner of RDY in this Form 3?

No, the Form 3 indicates that Israeli Erez is not a ten percent owner, with the is_ten_percent_owner field set to 0. He is reported solely in his capacity as CHIEF EXECUTIVE OFFICER and officer of the issuer.

Does the RDY Form 3 for Israeli Erez include any derivative securities information?

No, the derivativeSummary section is empty and derivativeTransactionCount is 0. This means the filing does not list any options, warrants, or other derivative securities positions or related transactions for Israeli Erez.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Israeli Erez

(Last) (First) (Middle)

LODHA BELLEZA, 5A, FN:3600, BENICIA,

EDEN SQUARE, HITECH CITY

(Street)

HYDERABAD TELANGANA 500072

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ EREZ ISRAELI	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)